Cover Image
市場調查報告書

血管新生青光眼:全球臨床實驗檢討 (2015年前半期)

Neovascular Glaucoma Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 324944
出版日期 內容資訊 英文 66 Pages
訂單完成後即時交付
價格
Back to Top
血管新生青光眼:全球臨床實驗檢討 (2015年前半期) Neovascular Glaucoma Global Clinical Trials Review, H1, 2015
出版日期: 2015年01月21日 內容資訊: 英文 66 Pages
簡介

本報告提供血管新生青光眼相關之臨床研究最新趨勢調查,提供您地區·進展·PHASE·募集情況別之實驗量,代表性贊助商,開發中的治療藥資訊,並彙整全球各國的主要企業·機關的進展狀況,及有潛力的藥劑比較等資訊。

簡介

  • 血管新生青光眼
  • 報告指南

各地區的臨床實驗數量

  • 各國臨床實驗數量及平均參加者數
    • 亞太地區主要國家的臨床實驗數量
    • 歐洲主要國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:眼科臨床實驗中血管新生青光眼的比例

G7各國臨床實驗數量:Phase別

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:眼科臨床實驗中血管新生青光眼的比例

E7各國臨床實驗數量:Phase別

E7各國臨床實驗數量:各進展狀況

Phase別臨床實驗數量

  • 進行中的臨床實驗:Phase別

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量:血管新生青光眼

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

  • 血管新生青光眼的治療藥臨床實驗的主要參與企業

有潛力的藥劑

臨床實驗簡介

  • 代表性企業臨床實驗概況
    • Gene Signal International SA
    • ODIN Biotech Partners, LLC
  • 主要的研究機關/政府機關/醫院臨床實驗概要
    • 熊本大學
    • Federal University of Sao Paulo
    • University of Illinois
    • 島根大學
    • Universidade Federal de Uberlandia
    • Hong Kong Eye Hospital
    • University of Lubeck
    • Faculty of Medicine Siriraj Hospital, Mahidol University
    • Shahid Beheshti University of Medical Sciences
    • Cairo University

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2530CTIDB

GlobalData's clinical trial report, "Neovascular Glaucoma Global Clinical Trials Review, H1, 2015" provides data on the Neovascular Glaucoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Neovascular Glaucoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Neovascular Glaucoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Neovascular Glaucoma
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Neovascular Glaucoma to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Neovascular Glaucoma to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Neovascular Glaucoma
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Neovascular Glaucoma Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Gene Signal International SA
      • Clinical Trial Overview of Gene Signal International SA
      • ODIN Biotech Partners, LLC
      • Clinical Trial Overview of ODIN Biotech Partners, LLC
    • Clinical Trial Overview of Top Institutes / Government
      • Kumamoto University
      • Clinical Trial Overview of Kumamoto University
      • Federal University of Sao Paulo
      • Clinical Trial Overview of Federal University of Sao Paulo
      • University of Illinois
      • Clinical Trial Overview of University of Illinois
      • Shimane University
      • Clinical Trial Overview of Shimane University
      • Universidade Federal de Uberlandia
      • Clinical Trial Overview of Universidade Federal de Uberlandia
      • Hong Kong Eye Hospital
      • Clinical Trial Overview of Hong Kong Eye Hospital
      • University of Lubeck
      • Clinical Trial Overview of University of Lubeck
      • Faculty of Medicine Siriraj Hospital, Mahidol University
      • Clinical Trial Overview of Faculty of Medicine Siriraj Hospital, Mahidol University
      • Shahid Beheshti University of Medical Sciences
      • Clinical Trial Overview of Shahid Beheshti University of Medical Sciences
      • Cairo University
      • Clinical Trial Overview of Cairo University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Neovascular Glaucoma Therapeutics, Global, Clinical Trials by Region, 2015*
  • Neovascular Glaucoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Neovascular Glaucoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Neovascular Glaucoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015*
  • Neovascular Glaucoma Therapeutics Clinical Trials, Europe, Top Countries, 2015*
  • Neovascular Glaucoma Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Neovascular Glaucoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Neovascular Glaucoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Neovascular Glaucoma to Ophthalmology Clinical Trials, G7 Countries (%), 2015*
  • Neovascular Glaucoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Neovascular Glaucoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Neovascular Glaucoma to Ophthalmology Clinical Trials, E7 Countries (%), 2015*
  • Neovascular Glaucoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Neovascular Glaucoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Neovascular Glaucoma Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Neovascular Glaucoma Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Neovascular Glaucoma Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Neovascular Glaucoma Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Neovascular Glaucoma Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Neovascular Glaucoma Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Neovascular Glaucoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Neovascular Glaucoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Neovascular Glaucoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Neovascular Glaucoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Neovascular Glaucoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Gene Signal International SA, 2015*
  • Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by ODIN Biotech Partners, LLC, 2015*
  • Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Kumamoto University, 2015*
  • Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2015*
  • Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Illinois, 2015*
  • Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Shimane University, 2015*
  • Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Universidade Federal de Uberlandia, 2015*
  • Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Hong Kong Eye Hospital, 2015*
  • Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Lubeck, 2015*
  • Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Faculty of Medicine Siriraj Hospital, Mahidol University, 2015*
  • Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Shahid Beheshti University of Medical Sciences, 2015*
  • Neovascular Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Cairo University, 2015*

List of Figures

  • Neovascular Glaucoma Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Neovascular Glaucoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Neovascular Glaucoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Neovascular Glaucoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015*
  • Neovascular Glaucoma Therapeutics Clinical Trials, Europe, Top Countries (%), 2015*
  • Neovascular Glaucoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Proportion of Neovascular Glaucoma to Ophthalmology Clinical Trials, G7 Countries (%), 2015*
  • Neovascular Glaucoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Neovascular Glaucoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Neovascular Glaucoma to Ophthalmology Clinical Trials, E7 Countries (%), 2015*
  • Neovascular Glaucoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Neovascular Glaucoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Neovascular Glaucoma Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Neovascular Glaucoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Neovascular Glaucoma Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Neovascular Glaucoma Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Neovascular Glaucoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Neovascular Glaucoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Neovascular Glaucoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Neovascular Glaucoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Neovascular Glaucoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top